These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15173838)

  • 1. Antibody-targeted radiation cancer therapy.
    Milenic DE; Brady ED; Brechbiel MW
    Nat Rev Drug Discov; 2004 Jun; 3(6):488-99. PubMed ID: 15173838
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted monoclonal antibody-based treatment of hematological malignancies.
    Kaspers GJ
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):253-5. PubMed ID: 12820769
    [No Abstract]   [Full Text] [Related]  

  • 3. Are targeted therapies really targeted?
    Schilsky RL
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):722-3. PubMed ID: 16258475
    [No Abstract]   [Full Text] [Related]  

  • 4. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technological advances in radioimmunotherapy.
    Dearling JL; Pedley RB
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):457-69. PubMed ID: 17537620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
    Sharkey RM; Goldenberg DM
    J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-based targeted radiation to pediatric tumors.
    Modak S; Cheung NK
    J Nucl Med; 2005 Jan; 46 Suppl 1():157S-63S. PubMed ID: 15653664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications.
    Bodei L; Paganelli G; Mariani G
    J Nucl Med; 2006 Mar; 47(3):375-7. PubMed ID: 16513604
    [No Abstract]   [Full Text] [Related]  

  • 9. Developing targeted therapies for lung cancer.
    Gandara DR
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
    [No Abstract]   [Full Text] [Related]  

  • 10. CD70 as a therapeutic target in human malignancies.
    Grewal IS
    Expert Opin Ther Targets; 2008 Mar; 12(3):341-51. PubMed ID: 18269343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapies: aiming for the bull's-eye.
    Gaguski ME
    ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanoparticle and targeted systems for cancer therapy.
    Brannon-Peppas L; Blanchette JO
    Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Antibodies in cancer treatment".
    Desoize B
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):23-5. PubMed ID: 17338979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibody and antibody-targeted therapy].
    Becker JC
    J Dtsch Dermatol Ges; 2006 Aug; 4(8):703. PubMed ID: 16895576
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic cancer: from molecular pathogenesis to targeted therapy.
    Strimpakos A; Saif MW; Syrigos KN
    Cancer Metastasis Rev; 2008 Sep; 27(3):495-522. PubMed ID: 18427734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology evaluation: ING-1, XOMA.
    Lewis LD
    Curr Opin Mol Ther; 2003 Aug; 5(4):433-6. PubMed ID: 14513688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent antibody drug conjugates for cancer therapy.
    Senter PD
    Curr Opin Chem Biol; 2009 Jun; 13(3):235-44. PubMed ID: 19414278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors.
    Nielsen DL; Andersson M; Kamby C
    Cancer Treat Rev; 2009 Apr; 35(2):121-36. PubMed ID: 19008049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets.
    Kvols LK
    J Nucl Med; 2005 Jan; 46 Suppl 1():187S-90S. PubMed ID: 15653668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences.
    Dassonville O; Bozec A; Fischel JL; Milano G
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):53-61. PubMed ID: 17324578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.